"If it works on Alz" - the probability that Xanamem will "cure" alzheimers is slim. But, given prior results, it is reasonable to speculate that it may prolong functional cognitive capacity of patients. And if the results are good, I think the target will be much higher than $1.
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis, page-67
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $94.93M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.7¢ | 3.4¢ | $220.0K | 6.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 265101 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 175641 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |